NCT03693534 is a clinical trial of Clinical Pregnancy Rate in Pregnancy, Ovarian, sponsored by Assisting Nature.

Who is sponsoring NCT03693534?

NCT03693534 is sponsored by Assisting Nature.

What drugs are being tested in NCT03693534?

Interventions in NCT03693534: Clinical Pregnancy Rate.

What condition does NCT03693534 study?

NCT03693534 studies Pregnancy, Ovarian.

Is NCT03693534 still recruiting?

NCT03693534 is currently status unknown. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT03693534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol

Status unknown Last updated 8 October 2020

What this trial tests

trial testing Clinical Pregnancy Rate in Pregnancy, Ovarian in 120 participants. Status unknown.

Timeline

15 February 2017

Primary endpoint
30 June 2021

30 June 2021

Quick facts

Lead sponsor	Assisting Nature
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	15 February 2017
Primary completion	30 June 2021
Estimated completion	30 June 2021
Sites	1 location across Greece

Drugs / interventions tested

Clinical Pregnancy Rate

Conditions studied

Pregnancy, Ovarian — all drugs for Pregnancy, Ovarian →

Sponsor

Assisting Nature

Who can join

Adults 18 to 39, female only, with Pregnancy, Ovarian. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective study of the evaluation of the clinical IVF (in vitro fertilization) results after following Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus following Long Agonist protocol

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assisting Nature trials

Trials by the same sponsor.

NCT03240159 — Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix · Phase 3 · unknown
NCT03684421 — Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol · unknown
NCT03463278 — The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03693534 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assisting Nature
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03693534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing